Diterpenes from Pinus kesiya var. langbianensis (A.Chev.) Gaussen ex Bui (Pinaceae) and their protective effects in LPS-treated BEAS-2B cells.

BEAS-2B Diterpene Pinaceae Pine resin Pinus kesiya var. langbianensis (A.Chev.) Gaussen ex Bui Protective effect Rosins A−H

Journal

Phytochemistry
ISSN: 1873-3700
Titre abrégé: Phytochemistry
Pays: England
ID NLM: 0151434

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 08 05 2022
revised: 24 07 2022
accepted: 29 07 2022
pubmed: 16 8 2022
medline: 12 10 2022
entrez: 15 8 2022
Statut: ppublish

Résumé

Eight previously undescribed diterpenoids, rosins A-H, and nine known diterpenoids were isolated from the resin from Pinus kesiya var. langbianensis (A.Chev.) Gaussen ex Bui (Pinaceae) extracted with 95% ethanol. Their structures were determined by nuclear magnetic resonance spectroscopy, mass spectrometry, J-based configuration analysis (JBCA), NOESY spectra, calculated NMR chemical shifts and electronic circular dichroic (ECD) spectra. All compounds were evaluated for their protective effects in LPS-treated human normal lung epithelial cells (BEAS-2B), and the cell viability was significantly increased after treatment with compounds 5, 10, 12, or 15 at a concentration of 10 μM.

Identifiants

pubmed: 35970437
pii: S0031-9422(22)00276-X
doi: 10.1016/j.phytochem.2022.113360
pii:
doi:

Substances chimiques

Diterpenes 0
Lipopolysaccharides 0
Ethanol 3K9958V90M

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113360

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Yu-Fei Liu (YF)

School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 450046, PR China.

Zhi-Min Song (ZM)

School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 450046, PR China.

Meng-Nan Zeng (MN)

School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 450046, PR China.

Yan-Zhi Wang (YZ)

School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 450046, PR China; Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases co-constructed by Henan province & Education Ministry of P.R. China, Zhengzhou, 450046, China. Electronic address: wangyz@hactcm.edu.cn.

Yong-Xian Cheng (YX)

Institute for Inheritance-Based Innovation of Chinese Medicine, School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, 518060, PR China.

Lin-Qing Qiao (LQ)

School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 450046, PR China.

Rui Peng (R)

School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 450046, PR China.

Wei-Sheng Feng (WS)

School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 450046, PR China; Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases co-constructed by Henan province & Education Ministry of P.R. China, Zhengzhou, 450046, China. Electronic address: fwsh@hactcm.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH